These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6031261)

  • 1. The effect of neuroleptics on the activity of central catecholamine neurones.
    Corrodi H; Fuxe K; Hökfelt T
    Life Sci; 1967 Apr; 6(7):767-74. PubMed ID: 6031261
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of ethanol on the activity of central catecholamine neurones in rat brain.
    Corrodi H; Fuxe K; Hökfelt T
    J Pharm Pharmacol; 1966 Dec; 18(12):821-3. PubMed ID: 4381667
    [No Abstract]   [Full Text] [Related]  

  • 3. The effects of barbiturates on the activity of the catecholamine neurones in the rat brain.
    Corrodi H; Fuxe K; Hökfelt T
    J Pharm Pharmacol; 1966 Aug; 18(8):556-8. PubMed ID: 4381869
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of catecholamine precursors and monoamine oxidase inhibition on the amine levels of central catecholamine neurons after reserpine treatment or tyrosine hydroxylase inhibition.
    Corrodi H; Fuxe K
    Life Sci; 1967 Jul; 6(13):1345-50. PubMed ID: 6035763
    [No Abstract]   [Full Text] [Related]  

  • 5. Behavioral effects of L-alpha-methyltyrosine, an inhibitor of tyrosine hydroxylase.
    Weissman A; Koe BK
    Life Sci; 1965 May; 4(10):1037-48. PubMed ID: 5838507
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of reserpine, alpha-methyl-m-tyrosine, prenylamine, and guanethidine on metrazol-convulsions and the brain monoamine level in mice.
    Pfeifer AK; Galambos E
    Arch Int Pharmacodyn Ther; 1967 Jan; 165(1):201-11. PubMed ID: 6030237
    [No Abstract]   [Full Text] [Related]  

  • 7. Difference in oral effectiveness of two tyrosine hydroxylase inhibitors.
    Johnson GA; Kim EG; Veldkamp W; Russell R
    Biochem Pharmacol; 1967 Feb; 16(2):401-3. PubMed ID: 6029921
    [No Abstract]   [Full Text] [Related]  

  • 8. Antagonism by monoamine oxidase inhibitors of alpha-methyltyrosine-induced catecholamine depletion and behavioral depression.
    Moore KE; Rech RH
    J Pharmacol Exp Ther; 1967 Apr; 156(1):70-5. PubMed ID: 6023602
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of the behavioral depressant effects of biogenic amine depleting and neuroleptic agents following various 6-hydroxydopamine treatments.
    Cooper BR; Grant LD; Breese GR
    Psychopharmacologia; 1973 Jul; 31(2):95-109. PubMed ID: 4722209
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of neuroleptics on endogenous norepinephrine in rat brain.
    Bartholini G; Keller HH; Pletscher A
    Neuropharmacology; 1973 Aug; 12(8):751-6. PubMed ID: 4746440
    [No Abstract]   [Full Text] [Related]  

  • 11. Importance of nervous impulse flow for the neuroleptic induced increase in amine turnover in central dopamine neurons.
    Andén NE; Corrodi H; Fuxe K; Ungerstedt U
    Eur J Pharmacol; 1971 Jul; 15(2):193-9. PubMed ID: 4341651
    [No Abstract]   [Full Text] [Related]  

  • 12. Histochemical fluorescence detection of changes in central monoamine neurones provoked by drugs acting on the CNS.
    Fuxe K; Hökfelt T
    Triangle; 1971; 10(3):73-84. PubMed ID: 5138525
    [No Abstract]   [Full Text] [Related]  

  • 13. The action of neuroleptics in rats with altered catecholamine metabolism. 3. The effect of chlorpromazine, haloperidol and thioridazine on the brain dopamine and serotonin contents in the rats pretreated with MAO inhibitors.
    Vetulani J
    Pol J Pharmacol Pharm; 1973; 25(1):65-83. PubMed ID: 4775865
    [No Abstract]   [Full Text] [Related]  

  • 14. Modification of the effects of tranquilizers in animals treated with alpha-methyl-l-tryrosine.
    Menon MK; Dandiya PC; Bapna JS
    J Pharmacol Exp Ther; 1967 Apr; 156(1):63-9. PubMed ID: 6023601
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of neuroleptic drugs on central catecholamine turnover assessed using tyrosine- and dopamine- -hydroxylase inhibitors.
    Andén NE; Corrodi H; Fuxe K
    J Pharm Pharmacol; 1972 Mar; 24(3):177-82. PubMed ID: 4402775
    [No Abstract]   [Full Text] [Related]  

  • 16. On the use of the fluorescence histochemical method to estimate catecholamine content in brain.
    Bacopoulos NG; Bhatnagar RK; Schnute WJ; Van Orden LS
    Neuropharmacology; 1975 Apr; 14(4):291-9. PubMed ID: 1128763
    [No Abstract]   [Full Text] [Related]  

  • 17. The action of neuroleptics in rats with altered catecholamine metabolism. II. The effects of chlorpromazine, haloperidol, and thioridazine on brain noradrenaline content elevated by previous administration of MAO inhibitors.
    Vetulani J
    Pol J Pharmacol Pharm; 1973; 25(1):53-64. PubMed ID: 4775864
    [No Abstract]   [Full Text] [Related]  

  • 18. Regional accumulation of catecholamines formed from tyrosine-14C in rat brain: effect of chlorpromazine.
    Nybäck H; Sedvall G
    Eur J Pharmacol; 1969 Feb; 5(3):245-52. PubMed ID: 5772674
    [No Abstract]   [Full Text] [Related]  

  • 19. Alterations in behavior and brain catecholamine levels in rats treated with alpha-methyltyrosine.
    Rech RH; Borys HK; Moore KE
    J Pharmacol Exp Ther; 1966 Sep; 153(3):412-9. PubMed ID: 5922318
    [No Abstract]   [Full Text] [Related]  

  • 20. Stress-related effects of various inhibitors of catecholamine synthesis in the mouse.
    Thornburg JE; Moore KE
    Arch Int Pharmacodyn Ther; 1971 Nov; 194(1):158-67. PubMed ID: 4399378
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.